drugset / Trial / NCT00660855

A Multicenter, Open Label Trial To Evaluate Pain Relief With Intravenous Followed By Oral Therapy With Parecoxib/Valdecoxib 40 Mg/Day For Treatment Of Post-Laparoscopic Surgery Pain

NCT00660855

Phase 4 Terminated 4 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The objectives of this study were to assess the analgesic efficacy and safety of parecoxib/valdecoxib on post-laparoscopic surgery analgesia.

Timeline

Start
2004-06
Primary completion
Completion
2004-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Parecoxib Small molecule 40 mg Intravenous
Subject valdecoxib Small molecule 40 mg Oral

Indications

No indication recorded.